MiRNA signature analysis in LSCC gene expression profiles indicates hsa-miR-299-5p as a new tumor suppressor

Area of Science:

• Molecular Biology
• Cancer Research
• Epigenetics

Background:

• Epigenetic alterations, including microRNA (miRNA) silencing, play a crucial role in cancer development by affecting tumor suppressor genes and oncogenes.
• Laryngeal squamous cell carcinoma (LSCC) is a significant global health concern, and understanding its molecular underpinnings is vital for developing effective therapies.

Purpose of the Study:

• To identify regulatory miRNA signatures associated with oncogene activation in LSCC.
• To investigate the role of hsa-miR-299-5p in LSCC pathogenesis and its potential as a therapeutic target.

Main Methods:

• Analysis of LSCC mRNA profiles to identify common miRNA signatures.
• RT-qPCR to validate miRNA and gene expression levels in LSCC cell lines and tumor samples.
• Dual luciferase assay to confirm direct interaction between hsa-miR-299-5p and TFAM.
• Functional studies involving miRNA mimicry to assess effects on TFAM protein levels and cell viability.

Main Results:

• Identification of 14 overexpressed genes sharing a common hsa-miR-299-5p regulatory signature in LSCC.
• Confirmation of hsa-miR-299-5p downregulation and overexpression of PATZ1, PURB, and TFAM in LSCC.
• Demonstration of a direct interaction between hsa-miR-299-5p and TFAM 3'UTR.
• Restored hsa-miR-299-5p activity led to decreased TFAM protein levels and reduced cell viability in LSCC cell lines.

Conclusions:

• hsa-miR-299-5p acts as a tumor-suppressive miRNA in LSCC.
• hsa-miR-299-5p regulates TFAM, influencing cell viability in laryngeal squamous cell carcinoma.
• hsa-miR-299-5p represents a potential therapeutic target for LSCC treatment.